focus -WSS

focus

author：fashion 2025-10-02 20:48:31 - browse：493

light shines behind Pfizer CEO Albert Bourla as he attends a ceremony in Greece — Pfizer CEO Albert Bourla Giannis Papanikos/AP

Pfizer has a big problem. The drug giant hopes that new drugs to treat cancer are the solution.

Shares in the drugmaker fell 44% last year, and it now has a market capitalization of only $150 billion — a quarter that of Eli Lilly and half that of longtime rival Merck. In March of last year the company announced that it would spend $43 billion to buy Seagen, a maker of a hot category of oncology medicines called antibody-drug conjugates. Pfizer’s shares have slumped another 9% so far this year. On Thursday, executives are holding an investor briefing to try to convince shareholders that its bet will pay off.

In an interview with STAT, Pfizer CEO Albert Bourla was insistent that the deal’s potential is being missed.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： 23andMe had bad news about my health. I wish a person had delivered it
Next article： Humana, CVS hope to turn members into patients at clinics

focus

WSS

Synthetic human embryos? Researchers say term is overblown

A cyberattack has disrupted hospitals and health care in several states

Prince Harry seeks over $550,000 in phone hacking lawsuit against British tabloid publisher

GOP hopefuls to address prominent, controversial group questioning what's taught in schools

CDC: Uninsured rate hit 'record low' right as states cut Medicaid

Biden slams SCOTUS affirmative action decision: 'Discrimination still exists in America'

explore

focus

knowledge

George Santos makes 1st court appearance after pleading not guilty to 13 counts

New lesbian bars spark hope amid disappearing LGBTQ+ spaces

Peter Hotez and the public health issue of online harassment

Biden calls for immediate release of Niger's president amid apparent coup

Medicare details structure of new drug price negotiation program

ER docs worry over extreme heat as a 'mass casualty event'

Peter Hotez and the public health issue of online harassment

Humana, CVS hope to turn members into patients at clinics

Peter Hotez and the public health issue of online harassment

GOP inquiry over gain

leisure time

Here's how to stay safe from wildfire smoke amid reduced air quality

White House drug shortage group privately met with industry

Here's how to stay safe from wildfire smoke amid reduced air quality

GOP hopefuls to address prominent, controversial group questioning what's taught in schools

Medical experts exlpore how to eliminate bias in clinical algorithms

Treeline, Josh Bilenker's next biotech, is cloaked in mystery

leisure time

focus

focus

knowledge